Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Visa, L; Jimenez-Fonseca, P; Martinez, EA; Hernandez, R; Custodio, A; Garrido, M; Viudez, A; Buxo, E; Echavarria, I; Cano, JM; Macias, I; Mangas, M; de Castro, EM; Garcia, T; Mancenido, FA; Montes, AF; Azkarate, A; Longo, F; Serrano, AD; Lopez, C; Hurtado, A; Cerda, P; Serrano, R; Gil-Negrete, A; Carnicero, AM; Pimentel, P; Ramchandani, A; Carmona-Bayonas, A; AGAMENON Study Grp.

Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer:. A real-world data, non-inferiority analysis

Journal of Geriatric Oncology. 2018; 9(3): 254-264 Nº de citas: 14 [doi:10.1016/j.jgo.2017.11.008]

Ethier, JL; Ocana, A; Lescure, AR; Ruiz, A; Alba, E; Calvo, L; Ruiz-Borrego, M; Santaballa, A; Rodriguez, CA; Crespo, C; Ramos, M; Marco, JG; Lluch, A; Alvarez, I; Casas, M; Sanchez-Arago, M; Carrasco, E; Caballero, R; Amir, E; Martin, M.

Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study

EUROPEAN JOURNAL OF CANCER. 2018; 94: 199-205 Nº de citas: 19 [doi:10.1016/j.ejca.2018.02.018]

Alvarez, R; Carrato, A; Adeva, J; Ales, I; Prados, S; Valladares, M; Macarulla, T; Munoz, A; Hidalgo, M.

Management of hyperbilirubinaemia in pancreatic cancer patients

EUROPEAN JOURNAL OF CANCER. 2018; 94: 26-36 Nº de citas: 10 [doi:10.1016/j.ejca.2018.01.078]

Echavarria, I; Lopez-Tarruella, S; Picornell, A; Garcia-Saenz, JA; Jerez, Y; Hoadley, K; Gomez, HL; Moreno, F; Del Monte-Millan, M; Marquez-Rodas, I; Alvarez, E; Ramos-Medina, R; Gayarre, J; Massarrah, T; Ocana, I; Cebollero, M; Fuentes, H; Barnadas, A; Ballesteros, AI; Bohn, U; Perou, CM; Martin, M.

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

CLINICAL CANCER RESEARCH. 2018; 24(8): 1845-1852 Nº de citas: 94 [doi:10.1158/1078-0432.CCR-17-1912]

Wapnir, IL; Price, KN; Anderson, SJ; Robidoux, A; Martin, M; Nortier, JWR; Paterson, AHG; Rimawi, MF; Lang, I; Baena-Canada, JM; Thurlimann, B; Mamounas, EP; Geyer, CE; Gelber, S; Coates, AS; Gelber, RD; Rastogi, P; Regan, MM; Wolmark, N; Aebi, S; NRG Oncology; GEICAM Spanish Breast Canc Grp; BOOG Dutch Breast Canc Trialists G; Breast Int Grp.

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial

JOURNAL OF CLINICAL ONCOLOGY. 2018; 36(11): 1073-1079 Nº de citas: 95 [doi:10.1200/JCO.2017.76.5719]

Palacios Calvo J; Albanell J; Rojo F; Ciruelos E; Aranda-Lopez I; Cortes J; Garcia-Caballero T; Martin M; Lopez-Garcia MA; Colomer R.

Consenso de la Sociedad Espanola de Anatomia Patologica y la Sociedad Espanola de Oncologia Medica sobre biomarcadores en cancer de mama.

Revista Espanola de Patologia. 2018; 51(2): 97-109 Nº de citas: 2 [doi:10.1016/j.patol.2017.12.002]

Rugo, HS; Dieras, V; Gelmon, KA; Finn, RS; Slamon, DJ; Martin, M; Neven, P; Shparyk, Y; Mori, A; Lu, DR; Bhattacharyya, H; Bartlett, CH; Iyer, S; Johnston, S; Ettl, J; Harbeck, N.

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

ANNALS OF ONCOLOGY. 2018; 29(4): 888-894 Nº de citas: 121 [doi:10.1093/annonc/mdy012]

Calvo-Ferrandiz, E; Peraita-Adrados, R.

Narcolepsy with cataplexy and pregnancy: a case-control study

JOURNAL OF SLEEP RESEARCH. 2018; 27(2): 268-272 Nº de citas: 22 [doi:10.1111/jsr.12567]

Martin, AJM; Ortega, I; Font, C; Pachon, V; Castellon, V; Martinez-Marin, V; Salgado, M; Martinez, E; Calzas, J; Ruperez, A; Souto, JC; Martin, M; Salas, E; Soria, JM.

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

BRITISH JOURNAL OF CANCER. 2018; 118(8): 1056-1061 Nº de citas: 101 [doi:10.1038/s41416-018-0027-8]

Hanna, GJ; Busaidy, NL; Chau, NG; Wirth, LJ; Barletta, JA; Calles, A; Haddad, RI; Kraft, S; Cabanillas, ME; Rabinowits, G; O'Neill, A; Limaye, SA; Alexander, EK; Moore, FD; Misiwkeiwicz, K; Thomas, T; Nehs, M; Marqusee, E; Lee, SL; Janne, PA; Lorch, JH.

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

CLINICAL CANCER RESEARCH. 2018; 24(7): 1546-1553 Nº de citas: 100 [doi:10.1158/1078-0432.CCR-17-2297]

Di Leo, A; Jerusalem, G; Torres, R; Verhoeven, D; Pendergrass, K; Malorni, L; Lichfield, J; Martin, M.

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

BREAST. 2018; 38: 144-149 Nº de citas: 12 [doi:10.1016/j.breast.2017.12.016]

Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J.

Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(4): 443-447 Nº de citas: 16 [doi:10.1007/s12094-017-1740-0]

Grothey, A; Yoshino, T; Bodoky, G; Ciuleanu, T; Garcia-Carbonero, R; Garcia-Alfonso, P; Van Cutsem, E; Muro, K; Mytelka, DS; Li, L; Lipkovich, O; Hsu, Y; Sashegyi, A; Ferry, D; Nasroulah, F; Tabernero, J.

Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set

Esmo Open. 2018; 3(3): Nº de citas: 15 [doi:10.1136/esmoopen-2018-000347]

Turner, NC; Finn, RS; Martin, M; Im, SA; DeMichele, A; Ettl, J; Dieras, V; Moulder, S; Lipatov, O; Colleoni, M; Cristofanilli, M; Lu, DR; Mori, A; Giorgetti, C; Iyer, S; Bartlett, CH; Gelmon, KA.

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

ANNALS OF ONCOLOGY. 2018; 29(3): 669-680 Nº de citas: 81 [doi:10.1093/annonc/mdx797]

Samaniego, R; Gutierrez-Gonzalez, A; Gutierrez-Seijo, A; Sanchez-Gregorio, S; Garcia-Gimenez, J; Mercader, E; Marquez-Rodas, I; Aviles, JA; Relloso, M; Sanchez-Mateos, P.

CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma

Cancer Immunology Research. 2018; 6(3): 267-275 Nº de citas: 60 [doi:10.1158/2326-6066.CIR-17-0198]

Alsina, M; Rivera, F; Ramos, FJ; Galan, M; Lopez, R; Garcia-Alfonso, P; Ales-Martinez, JE; Queralt, B; Anton, A; Carrato, A; Gravalos, C; Mendez-Vidal, MJ; Lopez, C; de Mena, IR; Tabernero, J; Giralt, J; Aranda, E; GICOR.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

TARGETED ONCOLOGY. 2018; 13(1): 69-78 Nº de citas: 3 [doi:10.1007/s11523-017-0536-z]

Abad, A; Martinez-Balibrea, E; Vieitez, JM; Alonso-Orduna, V; Alfonso, PG; Manzano, JL; Massuti, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Gravalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

ANNALS OF ONCOLOGY. 2018; 29(2): 439-444 Nº de citas: 9 [doi:10.1093/annonc/mdx737]

Karachaliou, N; Gonzalez-Cao, M; Crespo, G; Drozdowskyj, A; Aldeguer, E; Gimenez-Capitan, A; Teixido, C; Molina-Vila, MA; Viteri, S; Gil, MD; Algarra, SM; Perez-Ruiz, E; Marquez-Rodas, I; Rodriguez-Abreu, D; Blanco, R; Puertolas, T; Royo, MA; Rosell, R.

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Therapeutic Advances in Medical Oncology. 2018; 10: Nº de citas: 197 [doi:10.1177/1758834017749748]